1-[2-(3-methoxyphenyl)ethyl]piperidine | 461389-78-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-[2-(3-methoxyphenyl)ethyl]piperidine
• CAS: 461389-78-6
• 化学式: C₁₄H₂₁NO
• 分子量: 219.327
• InChiKey: DIYXOSMBSRCFAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[2-(3-methoxyphenyl)ethyl]piperidine 在 氢溴酸 作用下， 以 水 为溶剂， 反应 3.0h， 以88%的产率得到1-[2-(3-羟基苯基)乙基]哌啶
  参考文献：
  名称：

  Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

  摘要：

  In order to develop new cholinesterase agents effective against Alzheimer's disease (AD) we synthesized some phenylcarbamates structurally related to Rivastigmine and evaluated their in vitro and in vivo biological activity. Among the compounds which displayed the most significant in vitro activity, 1-[1-(3-dimethylcarbamoyloxyphenyl)ethyl]piperidine (31b), in addition to a simple and cheaper synthesis, showed lower toxicity and very similar therapeutic index in comparison with Rivastigmine. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.

  DOI：

  10.1016/s0223-5234(01)01324-1
• 作为产物：
  描述：

  3-甲氧基苯基乙酰氯 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 6.0h， 生成 1-[2-(3-methoxyphenyl)ethyl]piperidine
  参考文献：
  名称：

  Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

  摘要：

  In order to develop new cholinesterase agents effective against Alzheimer's disease (AD) we synthesized some phenylcarbamates structurally related to Rivastigmine and evaluated their in vitro and in vivo biological activity. Among the compounds which displayed the most significant in vitro activity, 1-[1-(3-dimethylcarbamoyloxyphenyl)ethyl]piperidine (31b), in addition to a simple and cheaper synthesis, showed lower toxicity and very similar therapeutic index in comparison with Rivastigmine. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.

  DOI：

  10.1016/s0223-5234(01)01324-1

文献信息

• Ambient Moisture Accelerates Hydroamination Reactions of Vinylarenes with Alkali‐Metal Amides under Air
  作者：Florian F. Mulks、Leonie J. Bole、Laia Davin、Alberto Hernán‐Gómez、Alan Kennedy、Joaquín García‐Álvarez、Eva Hevia

  DOI：10.1002/anie.202008512

  日期：2020.10.19

  A straightforward alkali‐metal‐mediated hydroamination of styrenes using biorenewable 2‐methyltetrahydrofuran as a solvent is reported. Refuting the conventional wisdom of the incompatibility of organolithium reagents with air and moisture, shown here is that the presence of moisture is key in favoring formation of the target phenethylamines over competing olefin polymerization products. The method

  据报道，使用可生物再生的2-甲基四氢呋喃作为溶剂进行的直接的碱金属介导的苯乙烯加氢胺化反应。驳斥有机锂试剂与空气和水分不相容的传统观点，此处表明，水分的存在是形成目标苯乙胺优于竞争性烯烃聚合产物的关键。该方法也与氨基钠兼容，后者在惰性气氛条件下作为高效催化剂显示出极好的前景。
• [EN] CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION<br/>[FR] COMPOSÉS CYCLIQUES PRÉSENTANT UNE FONCTIONNALITÉ 1,3 DIAMINO À UTILISER DANS LE TRAITEMENT D'UNE INFECTION À VIH
  申请人：UNIV PARIS DESCARTES

  公开号：WO2015181387A1

  公开（公告）日：2015-12-03

  The present invention relates to compounds, capable of activating HIV expression in reservoir cells, of formula (I) for use in the treatment of HIV infection.

  本发明涉及公式(I)的化合物，能够激活HIV储存细胞中的表达，用于治疗HIV感染。
• CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION
  申请人：Université Paris Descartes

  公开号：EP3148537A1

  公开（公告）日：2017-04-05
• Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease
  作者：C MUSTAZZA、A BORIONI、M GIUDICE、F GATTA、R FERRETTI、A MENEGUZ、M VOLPE、P LORENZINI

  DOI：10.1016/s0223-5234(01)01324-1

  日期：2002.2

  In order to develop new cholinesterase agents effective against Alzheimer's disease (AD) we synthesized some phenylcarbamates structurally related to Rivastigmine and evaluated their in vitro and in vivo biological activity. Among the compounds which displayed the most significant in vitro activity, 1-[1-(3-dimethylcarbamoyloxyphenyl)ethyl]piperidine (31b), in addition to a simple and cheaper synthesis, showed lower toxicity and very similar therapeutic index in comparison with Rivastigmine. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.